Helsana HealthInvest, a subsidiary of the leading Swiss health insurance provider Helsana, invests in startups and venture funds in the digital health sector across Europe since 2021. The fund aims to improve efficiency and care delivery within the Swiss healthcare system. By investing in companies with scalable business models, the fund aims to benefit from the growth of digital health solutions in the European market and their potential application within Helsana's existing healthcare ecosystem. Portfolio companies gain insights, access, and collaboration opportunities with Helsana and its partners to validate solutions. With access to Helsana's large customer base (1.4 million individuals and 60,000 corporate clients), portfolio companies benefit from a faster market entry. Helsana HealthInvest focuses on startups that improve patient access to healthcare. This includes areas such as telemedicine, remote patient monitoring, digital therapeutics, and other innovative solutions that enhance the patient experience and improve health outcomes. The fund is particularly interested in companies that are already active in or want to enter the Swiss market, leveraging Helsana's strong presence and deep understanding of the Swiss healthcare landscape. Helsana HealthInvest also considers investments in fintech, insurtech, and cybersecurity, further expanding its scope beyond traditional healthcare startups, and providing diversification within a broader health-related investment universe. The fund does not invest in biotechnology, life sciences, or pharma.
Preferred startup development maturity for initial funding deployment.
Digital Health, Fintech, Insurtech, Cybersecurity
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...